Irinotecan Liposome in Combination With 5-FU/LV Versus 5-FU/LV in Second-line Therapy for Gemcitabine-Refractory Pancreatic Cancer

Take this into the appointment.

Saves the questions and what to expect into your notes, next to the visit they belong to.

Keep this study